Our company vision is to create new therapeutic drugs, which cover unmet medical needs. To achieve this, our strategy is to collaborate with other companies who share our business vision.
Our sigma-1 receptor program has the potential to deliver new CNS drugs. We are seeking a partner to develop our two sigma-1 agonists.
We are interested in any new drug seeds/leads in the ophthalmology therapeutic area. We are always ready to evaluate new technology and drug ideas in ophthalmology from academia and industry.
Please contact us at